Status:
UNKNOWN
the Difference of Follow-up Methods of Neonatal Jaundice
Lead Sponsor:
Guizhou Provincial People's Hospital
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
Up to 16 years
Brief Summary
The goal of this observational study is to compare the effectiveness and efficiency for precaution of severe hyperbilirubinemia in neonate by different follow-up methods of neonatal jaundice. There ar...
Eligibility Criteria
Inclusion
- Gestational age ≥ 28 weeks, corrected gestational age ≤ 44 weeks;
- Presence of skin yellowing, percutaneous measurement of jaundice or serum bilirubin concentration less than the phototherapy warning value for the same gestational age and day age group;
- The vital signs are stable and meet the discharge requirements;
- Agree to participate in this project and sign an informed consent form;
- Parents have a certain understanding ability to cooperate in this study;
Exclusion
- Direct bilirubin ≥34mmol/L;
- Increased hepatic enzyme level more than twice of normal value;
- Those infants who have developed bilirubin encephalopathy or neurological damage due to other reasons before follow-up;
- Unable to continue follow-up due to other diseases.
Key Trial Info
Start Date :
October 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 10 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06075290
Start Date
October 10 2023
End Date
May 10 2025
Last Update
November 2 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
People's Hospital of Anshun City Guizhou Province
Anshun, Guizhou, China, 561001
2
The First Affiliated Hospital of Guizhou University of Chinese
Guiyang, Guizhou, China, 550001
3
Guizhou Provincial People's Hospital
Guiyang, Guizhou, China, 550002